The World Health Organization (WHO) Global TB Programme and the WHO Collaborating Centre in TB Research at McGill University, Montreal, Canada convened a two-day technical consultation on research on latent TB infection

Research on Latent TB Infection

Technical consultation on latent TB infection management: Research for scale-up and target regimen profiles.

The World Health Organization (WHO) Global TB Programme and the WHO Collaborating Centre in TB Research at McGill University, convened a two-day technical consultation on research on latent TB infection.

The first day of the meeting focused on research needs to overcome key barriers and knowledge gaps affecting the scale-up of TB preventive treatment. Experts reviewed recent advances in diagnosis and treatment of LTBI and shared implementation experience generated over the past 5 years. A revised priority list of research topics was discussed, covering diagnosis, treatment and implementation research. 

Dr. Dick Menzies was interviewed. Dr. Menzies is a RESP Program member and an Associate Member of the Meakins-Christie Laboratories was interviewed. His research focuses on clinical and epidemiologic aspects of tuberculosis. His clinical research involves diagnosis of latent as well as active TB.

Read more here.